| Literature DB >> 35968415 |
Abstract
Chronic inhalation of titanium dioxide or carbon black by rats at concentrations which overload lung particle clearance can result in lung cancer. Based on this rat lung response, IARC, NIOSH, and ECHA classified titanium dioxide, and IARC classified carbon black, as potential human carcinogens. These classifications have been questioned based on an extensive data base demonstrating: the rat lung cancer occurred only under conditions of extreme lung particle overload; the lung cancer response in rats has not been seen in other animal species; and studies in titanium dioxide and carbon black exposed human populations have not shown an increased incidence of cancer. In 2019 an international panel of science and regulatory experts was convened to document the state of the science on lung particle overload and rat lung cancer after exposure to poorly soluble low toxicity particles. Regarding hazard identification, the expert panel concluded, in the absence of supporting data from other species, lung particle overload-associated rat lung cancer does not imply a cancer hazard for humans. Regarding high to low dose extrapolation, the expert panel concluded rat lung tumors occurring only under conditions of lung particle overload are not relevant to humans exposed under non-overloading conditions. The conclusions of the Edinburgh Expert Panel directly conflict with IARC, ECHA and NIOSH's extrapolation of lung particle overload associated rat lung cancer to hazard for humans. The hazard classifications for titanium dioxide and carbon black inhalation should be assessed considering the state-of-the-science on lung particle overload and rat lung cancer.Entities:
Keywords: carbon black; hazard classification; lung overload; rat lung cancer; titanium dioxide
Mesh:
Substances:
Year: 2022 PMID: 35968415 PMCID: PMC9366718 DOI: 10.3389/fpubh.2022.907318
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Chronic inhalation studies in rats producing lung cancer.
|
|
|
|
|
|
|---|---|---|---|---|
|
|
|
| ||
| Carbon Black | 11.6 | 43.8 | Yes | ( |
| Carbon Black | 2.5 | 21.0 | Yes | ( |
| 6.5 | 38.5 | Yes | ||
| Talc | 6 | 9.7 | No | ( |
| 18 | 26.7 | Yes | ||
| Titanium Dioxide | 10 | 39.2 | Yes | ( |
| Titanium Dioxide | 10 | 25.5 | No | ( |
| 50 | 124.0 | No | ||
| 250 | 665 | Yes |
Lung burden normalized to air control lung weight (g).
Edinburg Workshop Expert Panelists.
| Armelle Baeza-Squiban, Ph.D. | Professor, Functional and Adaptive Biology, Paris Diderot, University |
| Flemming Cassee, Ph.D. | National Institute for Public Health and the Environment, Netherlands |
| Rodger Duffin, Ph.D., MRC Path, FRSB | Reader in Respiratory Medicine, University of Edinburgh |
| Tom Gebel, Prof. Dr. | German Federal Institute for Occupational Safety and Health |
| Helmut Greim, M.D. | Technical University Munich |
| Uwe Heinrich, Dr. rer. nat. | Toxicology and Aerosol Research, Medizinische Hochschule, Hannover |
| Wolfgang G. Kreyling, Dr. rer. Nat. | German Research Center for Environmental Health |
| Robert Landsiedel, Dr. rer. nat. habil. | BASF SE. Experimental Toxicology and Ecology |
| Len Levy, Ph.D. | Cranfield University |
| Dominique Lison, M.D. Ph.D. | Louvain Centre for Toxicology and Applied Pharmacology (LTAP) |
| Fred J. Miller., Ph.D. | Inhalation Toxicology Division, US EPA; Fred Miller and Associates |
| Günter Oberdörster, Prof | Dept of Environ. Medicine, University of Rochester School of Medicine and Dentistry |
| Lang Tran, Ph.D. | Institute of Occupational Medicine, Edinburgh, UK |
| David B Warheit, Ph.D. | Warheit Scientific LLC |
| Mei Yong, Dr. rer. Medic. | Inst. for Occup. Epidemiology and Risk Assessment, Evonik Technology and Infrastructure |
Edinburgh Workshop Observers.
| Damjana Drobne | University of Ljubljana, Biotechnical Faculty (SL) |
| Craig Boreiko | Consultant to Antimony Association |
| Fiona Murphy | Herriot Watt University- Edinburgh; Member of the EU GRACIOUS Consortium |
| Annie Jarabek | U.S. EPA, National Center for Environmental Assessment (NCEA) |
| Terry Gordon | New York University School of Medicine, ACGIH TLV Committee |
| Klaus Kamps | Unifrax; Chair of Eurometaux REACH working group |
| Roger Battersby | EBRC Consulting |
| Frank Luetzenkirchen | Quarzwerke GmbH, Frechen, Germany (DE); IMA-Europe: Chairman IMA Technical Board |
| Robert McCunney | Harvard Medical School; Consultant to International Carbon Black Association |
| David Lockley | Product Defense and Toxicology Manager, Venator Corp; Chair of Scientific Committee and CLH TF, TDMA |
| Sue Hubbard | Consultant Regulatory Toxicologist Sah Co., Ltd. (UK); Member of Iron Platform |
| Andrew Smith | Health and Safety Executive (UK); Chemicals Regulation Division, Team leader: REACH-CLP-PIC; Member of ECHA's Risk Assessment Committee |
| Tim Bowmer | European Chemicals Agency (ECHA); Chairman of the Committee for Risk Assessment |
| Ari Karjalainen | European Chemicals Agency (ECHA), Unit C1—Hazard I |
| Yufanyi Ngiewih | Orion Engineered Carbons GmbH; ICBA Scientific Advisory Board |